View Older Stories View More Recent Stories

Feb 13, 2015 08:42AM Eco-Stim Energy Solutions Announces Pricing of Public Offering of Common Stock

Feb 13, 2015 08:29AM Cytokinetics (CYTK) Surpasses FY14 Estimates Following Recent Astellas Deal; Roth Cap. Affirms at 'Buy'

Feb 12, 2015 08:12AM ImmunoCellular Therapeutics (IMUC) Prices Stock and Warrants Offeirng

Feb 12, 2015 08:12AM ImmunoCellular Therapeutics (IMUC) Prices 26.65M Common, 18.66M Warrants Offering

Feb 11, 2015 12:56PM Ohr Pharmaceutical (OHRP) Closes 4.26M Common Offering; Gross Proceeds at ~$28.8M

Feb 11, 2015 12:16PM Streetinsider.com's Hot Lunchtime Reads 2/11: (AAPL) (OC) (IMMR) (FB)

Feb 11, 2015 11:39AM 2015 Expected to be 'Transformative' Year for Applied Genetic Technologies (AGTC) - Roth Capital

Feb 11, 2015 10:37AM Notable Analyst Rating Changes 2/11: (NUS) (NSP) (YELP) Upgraded; (WMT) (XLS) (ATEN) Downgraded

Feb 11, 2015 08:54AM Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital

Feb 11, 2015 08:39AM Delcath Systems (DCTH) Prices 2.46M Common Offering at $1.15/Share

Feb 11, 2015 06:50AM Roth Capital Upgrades Insperity (NSP) to Buy

Feb 10, 2015 04:55PM Delcath Systems (DCTH) to Offer Common Stock And Warrants

Feb 10, 2015 09:08AM RedHill Biopharma (RDHL) Prices 1M Offering at $12.50/ADS

Feb 10, 2015 08:33AM Roth Capital Starts CECO Environmental (CECE) at Neutral

Feb 9, 2015 04:46PM RedHill Biopharma (RDHL) Reports Proposed Public Offering of ADS

Feb 9, 2015 10:10AM Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering

Feb 9, 2015 07:03AM Roth Capital Starts Vermillion (VRML) at Buy

Feb 6, 2015 10:39AM Notable Analyst Rating Changes 2/6: (IMGN) (FBP) (WWE) Upgraded; (YELP) (P) (VIAB) Downgraded

Feb 6, 2015 10:08AM Roth Cuts PT on Synta Pharma (SNTA) to $20; Still Attractively Priced Given Ganetespib Potential

Feb 6, 2015 08:46AM Ohr Pharmaceutical (OHRP) Prices 3.7M Common Offering at $6.75/Share

Feb 6, 2015 06:43AM Roth Capital Resukmes Acadia Pharmaceuticals (ACAD) at Buy

Feb 4, 2015 09:17AM Roth Positive on Can-Fite Bio Pharma (CANF) Following Completion of CF101 Phase 2/3

Feb 4, 2015 09:04AM Catyalyst Pharmaceutical (CPRX) Prices 10M Shares at $3.25/Share

Feb 4, 2015 08:15AM Tonix Pharmaceuticals (TNXP) Prices 4.9M Common Offering at $5.85/Share

Feb 3, 2015 04:04PM Tonix Pharmaceuticals (TNXP) Plans Common Stock Offering

Feb 3, 2015 04:04PM Tonix Pharmaceuticals (TNXP) to Offer Common Stock

Feb 3, 2015 12:20PM Streetinsider.com's Hot Lunchtime Reads 2/3: (SLXP) (MMM) (TRP) (AAPL) (FNMA)

Feb 3, 2015 11:52AM Canadian Solar (CSIQ) Acquisition of Recurrent Energy Should Boost N. American Pipeline - Roth Capital

Feb 3, 2015 10:18AM Ligand's (LGND) License with Sermonix Demonstrates Great Example of Core Business Model - Roth Capital

Feb 2, 2015 02:43PM Roth Capital Positive on BioBlast Pharma (ORPN) CEO Appointment; Affirms at 'Buy'

Feb 2, 2015 10:20AM Notable Analyst Rating Changes 2/2: (DMND) (CPLP) (DECK) Upgraded; (GES) (GHL) (ARR) Downgraded

Feb 2, 2015 09:45AM UPDATE: Roth Capital Starts Hannon Armstrong (HASI) at Buy

Feb 2, 2015 07:39AM Roth Capital Upgrades Quiksilver (ZQK) to Buy

Jan 29, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 1/29: (AAPL) (PCYC) (AERI) (AMZN)

Jan 29, 2015 11:50AM Roth Capital Bumps PT on Pharmacyclics (PCYC) to $189 Following Expanded IMBRUVICA Indication

Jan 29, 2015 10:27AM Flex Pharm (FLKS) IPO Opens Up 19%

Jan 28, 2015 08:33AM Synergy Resources (SYRG) Prices 16.2M Share Offering at $10.75/Share

Jan 28, 2015 07:57AM Roth Remains Positive on Ligand (LGND) Following Kyprolis Q4 Sales Data, sNDA Filing (AMGN)

Jan 27, 2015 10:32AM Zosano Pharma (ZSAN) IPO Opens Higher

Jan 27, 2015 08:26AM Zosano Pharma (ZSAN) Prices 4.5M Common IPO at $11/Share

Jan 27, 2015 08:24AM Zosano Pharma Announces Pricing of Initial Public Offering

Jan 26, 2015 09:41AM Regeneron (REGN), Sanofi (SNY) on 'Last Stretch' of Praluent Development - Roth Capital

Jan 23, 2015 01:52PM Roth Capital Trims Verastem (VSTM) PT to $23 Followng Financing Activity

Jan 23, 2015 09:52AM Roth Capital Downgrades Uroplasty (UPI) to Neutral

Jan 22, 2015 06:41AM Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share

Jan 21, 2015 07:53PM Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

Jan 21, 2015 02:30PM Roth Affirms Curis (CRIS) at 'Buy' Following Aurigene Deal; Cuts PT to $6 on Dilution

Jan 20, 2015 09:24AM Roth Capital Affirms Verastem (VSTM) at 'Buy'; VS-6063, VS-5584 Combo Study Initiated

Jan 16, 2015 01:55PM Peregrine Pharma (PPHM) Starts 2015 Right with Strong Bavituximab in HCC Data - Roth Capital

Jan 16, 2015 01:09PM Unusual 11 Mid-Day Movers 1/16: (ASPS) (CRRC) (EOPN) Higher; (KONE) (NES) (PCP) Lower

View More Recent Stories View Older Stories